This is an old revision of the document!
Coronavirus
Infectivity
Coronavirus infections historically were associated with mild upper respiratory tract diseases in infants, children, and adults. Human coronavirus (HCoV)-OC43 and HCoV-229E were associated with 15–30% of common colds in winter and occasionally linked with lower respiratory tract disease in populations with chronic underlying diseases. HCoV research was complicated by the lack of a reverse genetic system or animal model. These viruses propagated poorly, and the number of reagents was limited. However, coronaviruses are capable of rapid host switching and evolution in changing ecologies (1), suggesting that their diversity and role in human disease were underappreciated. The 21st century heralded the arrival of the more pathogenic coronaviruses, like severe acute respiratory syndrome (SARS)-CoV.
https://web.archive.org/web/20180604062832/https://www.pnas.org/content/102/23/8073
SARS-Like Coronaviruses
Receptor Binding Domain
- Feb, 2008 - Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin1)
Characteristics
- Feb 6, 2020 - Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents2)
Chimeras
Humanized mice develop coronavirus respiratory disease Ralph S. Baric and Amy C. Sims PNAS June 7, 2005. 102 (23) 8073-8074; https://doi.org/10.1073/pnas.0503091102
1)
February, 2008 | Wuze Ren et al | Journal of Virology | doi: 10.1128/JVI.01085-07
2)
February 6, 2020 | Gunther Kampf et al | The Journal of Hospital Infection | Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents | DOI:https://doi.org/10.1016/j.jhin.2020.01.022